- Home
- IOBT vs XCUR Comparison
IOBT vs XCUR Comparison
Compare IOBT & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- XCUR
- Stock Information
- Founded
- IOBT 2014
- XCUR 2011
- Country
- IOBT Denmark
- XCUR United States
- Employees
- IOBT N/A
- XCUR N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- IOBT Health Care
- XCUR Health Care
- Exchange
- IOBT Nasdaq
- XCUR Nasdaq
- Market Cap
- IOBT 79.7M
- XCUR 67.8M
- IPO Year
- IOBT 2021
- XCUR N/A
- Fundamental
- Price
- IOBT $1.60
- XCUR $10.09
- Analyst Decision
- IOBT Strong Buy
- XCUR
- Analyst Count
- IOBT 3
- XCUR 0
- Target Price
- IOBT $9.33
- XCUR N/A
- AVG Volume (30 Days)
- IOBT 147.9K
- XCUR 11.5K
- Earning Date
- IOBT 05-14-2025
- XCUR 06-16-2025
- Dividend Yield
- IOBT N/A
- XCUR N/A
- EPS Growth
- IOBT N/A
- XCUR N/A
- EPS
- IOBT N/A
- XCUR N/A
- Revenue
- IOBT N/A
- XCUR $500,000.00
- Revenue This Year
- IOBT N/A
- XCUR N/A
- Revenue Next Year
- IOBT N/A
- XCUR N/A
- P/E Ratio
- IOBT N/A
- XCUR N/A
- Revenue Growth
- IOBT N/A
- XCUR N/A
- 52 Week Low
- IOBT $0.66
- XCUR $1.44
- 52 Week High
- IOBT $1.73
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- IOBT 78.81
- XCUR 42.90
- Support Level
- IOBT $1.09
- XCUR $9.01
- Resistance Level
- IOBT $1.29
- XCUR $10.00
- Average True Range (ATR)
- IOBT 0.12
- XCUR 0.39
- MACD
- IOBT 0.05
- XCUR -0.04
- Stochastic Oscillator
- IOBT 88.21
- XCUR 36.53
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.